Literature DB >> 22569901

Myocardial infarction in two cousins heterozygous for ASN41HIS autosomal dominant variant of Bernard-Soulier syndrome.

Antonio Girolami1, Silvia Vettore, Fabrizio Vianello, Giulia Berti de Marinis, Fabrizio Fabris.   

Abstract

Bernard-Soulier Syndrome is characterized by thrombocytopenia with large platelets and defective aggregation to ristocetin. The bleeding tendency is variable but may be severe. The syndrome is due to genetic defects of the GPIb-V-IX complex and it has been maintained to be protective from thrombotic events. Here we present the first two cases of documented M.I. in two cousins, heterozygous for the Arg41His mutation which is responsible for a dominant form of Bernard-Soulier Syndrome. In one of the two patients an aneurysm of the aorta was also present. The patients had a mild bleeding tendency which was severely aggravated by treatment with antiplatelet drugs. These clinical observations are in contrast with experimental studies which demonstrate that Bernard-Soulier-like strains of mice show a decreased thrombus generation in several experimental settings.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22569901     DOI: 10.1007/s11239-012-0742-6

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  27 in total

Review 1.  Are patients with Glanzmann thrombasthenia and the Bernard-Soulier syndrome protected against atherosclerosis?

Authors:  A T Nurden; P Nurden; J N George
Journal:  Adv Exp Med Biol       Date:  2001       Impact factor: 2.622

2.  Atherosclerosis and unstable angina in Bernard-Soulier syndrome.

Authors:  J E Humphries; B A Yirinec; C E Hess
Journal:  Am J Clin Pathol       Date:  1992-05       Impact factor: 2.493

3.  Severe proximal deep vein thrombosis in a Glanzmann thrombasthenia variant successfully treated with a low molecular weight heparin.

Authors:  Y Gruel; G Pacouret; S Bellucci; J Caen
Journal:  Blood       Date:  1997-07-15       Impact factor: 22.113

Review 4.  Myocardial infarction and other arterial occlusions in hemophilia a patients. A cardiological evaluation of all 42 cases reported in the literature.

Authors:  A Girolami; E Ruzzon; F Fabris; C Varvarikis; R Sartori; B Girolami
Journal:  Acta Haematol       Date:  2006       Impact factor: 2.195

5.  Variant Bernard-Soulier syndrome type bolzano. A congenital bleeding disorder due to a structural and functional abnormality of the platelet glycoprotein Ib-IX complex.

Authors:  L De Marco; M Mazzucato; F Fabris; D De Roia; P Coser; A Girolami; V Vicente; Z M Ruggeri
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

6.  Thrombotic events in MYH9 gene-related autosomal macrothrombocytopenias (old May-Hegglin, Sebastian, Fechtner and Epstein syndromes).

Authors:  Antonio Girolami; Girolami Antonio; Silvia Vettore; Vettore Silvia; Emanuela Bonamigo; Bonamigo Emanuela; Fabrizio Fabris; Fabris Fabrizio
Journal:  J Thromb Thrombolysis       Date:  2011-11       Impact factor: 2.300

7.  Decreased thrombotic tendency in mouse models of the Bernard-Soulier syndrome.

Authors:  C Strassel; C Nonne; A Eckly; T David; C Leon; M Freund; J-P Cazenave; C Gachet; F Lanza
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-11-09       Impact factor: 8.311

Review 8.  Thrombotic complications in patients with hereditary bleeding disorders.

Authors:  Massimo Franchini
Journal:  Thromb Haemost       Date:  2004-08       Impact factor: 5.249

Review 9.  Inherited platelet-based bleeding disorders.

Authors:  M Cattaneo
Journal:  J Thromb Haemost       Date:  2003-07       Impact factor: 5.824

Review 10.  Inherited traits affecting platelet function.

Authors:  Isabelle I Salles; Hendrik B Feys; Brecht F Iserbyt; Simon F De Meyer; Karen Vanhoorelbeke; Hans Deckmyn
Journal:  Blood Rev       Date:  2008-01-03       Impact factor: 8.250

View more
  1 in total

1.  Antithrombotic prophylaxis for surgery-associated venous thromboembolism risk in patients with inherited platelet disorders. The SPATA-DVT Study.

Authors:  Francesco Paciullo; Loredana Bury; Patrizia Noris; Emanuela Falcinelli; Federica Melazzini; Sara Orsini; Carlo Zaninetti; Rezan Abdul-Kadir; Deborah Obeng-Tuudah; Paula G Heller; Ana C Glembotsky; Fabrizio Fabris; Jose Rivera; Maria Luisa Lozano; Nora Butta; Remi Favier; Ana Rosa Cid; Marc Fouassier; Gian Marco Podda; Cristina Santoro; Elvira Grandone; Yvonne Henskens; Paquita Nurden; Barbara Zieger; Adam Cuker; Katrien Devreese; Alberto Tosetto; Erica De Candia; Arnaud Dupuis; Koji Miyazaki; Maha Othman; Paolo Gresele
Journal:  Haematologica       Date:  2019-09-26       Impact factor: 9.941

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.